Companies starting with C
A mission to improve patient safety and outcomes
We design and build products for patient simulation, surgical simulation, ultrasound simulation and clinical simulation management. CAE Healthcare is committed to advancing medical training and education for today’s healthcare practitioners and learners. We develop simulation-based technologies, curriculum and resources that improve clinical performance. With an emphasis on innovative solutions, simulation expertise and world class support, we deliver products and services to help prepare interprofessional clinical teams. Our solutions are designed to improve confidence, competency and teamwork for better patient outcomes. In 2017, CAE is celebrating its 70th anniversary. Over the last few decades, to shape the future of training, we’ve built on our diversity, our passion for excellence, and the talent of our employees all over the world. We may be many, but we succeed as one. One CAE!
CAF-DCF is een Belgische vennootschap, die zich gespecialiseerd heeft in de productie van stabiele plasmaderivaten: stollingsfactoren, immunoglobulinen en albumine oplossingen. Voor de bereiding van deze plasmaderivaten voor de Belgische gezondheidszorg, wordt plasma gebruikt, afgenomen bij vrijwillige en onbetaalde donoren. De inzet van dit bloedplasma afgestaan door de donor en de aanmaak van producten voor patiënten vormen de hoeksteen van een "human to human approach".
Created in 2001, congres-medical.com is the first platform referencing and promoting medical events. Congres-medical.com is also a directory listing of websites, sites and companies providing the event. The site offers publishing tools allowing members to announce, reference, share, broadcast content moderated and validated by the team of congres-medical.com in the field of health, (Congress, Congress exhibition venues, event service providers, medical providers,...). Under "News" has become a directory of content aggregation and distribution of information. "RSS (Really Simple Syndication)" is the new standard for exchange of content. It is performed by a professional team in partnership with info-live.com (French version). The ambition of writing congres-medical.com is to inform users and professionals independently with great attention to quality and reliability. The editorial team runs, detects, moderates, validates and distribute all the contents on social network and partner websites. For communication without borders ! Thank you for your attention and loyalty. **congres-medical.com is totally free**
ConvaTec is a leading developer and marketer of innovative medical technologies that have helped improve the lives of millions of people worldwide. With four key focus areas - Ostomy Care, Wound Therapeutics, Continence and Critical Care and Infusion Devices - ConvaTec products support healthcare professionals from the hospital to the community health setting. For more information, please visit: www.convatec.com.
A global pioneer in medical breakthroughs, Cook Medical is committed to creating effective solutions that benefit millions of patients worldwide. Today, we combine medical devices, drugs, biologic grafts and cell therapies across more than 16,000 products serving more than 40 medical specialties. Founded in 1963 by a visionary who put patient needs and ethical business practices first, Cook is a family-owned company that has created more than 10,000 jobs worldwide. For more information, visit our website.
C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. Its vascular products cover a range of minimally invasive devices for the treatment of peripheral vascular disease and end-stage renal disease. Its urology products include basic urology drainage products, fecal and urinary continence products, urological specialty products and Targeted Temperature Management products. Its oncology products cover a range of devices used in the treatment and management of various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation devices for hernia and soft tissue repairs.
Proud disseminating the great work of others
Critical Care Northampton is an online resource for all that is FOAMed / FOAMcc and of course POCUS. We have an ever expanding following with a growing team and provide weekly updates on what is big and being talked about within Critical Care. Our other aim is to provide a wealth of useful resources; to download, learn from and teach with. We also feature regular blogs on hot topics / areas of controversy welcoming guest publishers. We pride ourselves in disseminating the great work of others, whether web based or not, and continue to expand this network so others may benefit from it. The International Fluid Academy is just one of those links we are very proud to have.
As I learn you learn too
My name is Jonathan Downham and I am an Advanced Critical Care Practitioner in Warwick, UK.
I have worked in Critical Care for over 20 years now and have learned many things whilst there. This site has some of my teaching resources, podcasts and videos for anyone else to benefit from.
If you want to follow me on Twitter then look for @ccpractitioner. I am very active on there and it is the best way to get in touch with me quickly.
Promoting Open Access to Scientific Advancement
The ultimate aim of this site is to provide a single structured resource for accessing scientific advancement in the field of critical care. This is primarily provided via links to open access articles from across the entire medical literature. In addition to many mainstream journals providing open access to their published articles, either immediately or after a period of time, many journals less familiar to intensivists also publish freely available articles. In keeping with the modern development of open access journals, links to many of whom are provided, this website aims to enable visitors freely access important scientific advances within the speciality. Links to freely accessible podcasts and vodcasts, many from from major international meetings, are also available. Each week a specific topic is chosen for review and is displayed in "This Week's Papers". A featured article on this topic is presented daily in the the "Paper of the Day" section and provides an easy way to stay up-to-date with current developments in critical care. In a similar manner, recent publications from the major journals are highlighted in the "Journal Watch" section and a newsletter containing the week's developments in critical care is emailed to all registered users weekly. All papers are handpicked from across the spectrum of medical and scientific literature and are available from the publisher without charge. These articles can alternatively be accessed via search engines such as Google Scholar or PubMed. Articles are not stored on this website and all traffic is directed to the journal's website from where files are accessed. Due to the size of the critical care literature it will take a long time before most major topics are covered. If there are specific papers you wish to see added please email me and I can update the site accordingly. Similarly, if any broken links are found please let me know. Through the "Paper of the Day" facility, all areas of critical care will be focused upon in turn, enabling incomplete topics to be completed.
CytoSorbents is a critical care immunotherapy company commercializing its CE approved CytoSorb, a safe and effective cytokine adsorber. CytoSorb is designed to attenuate the dysregulated, hyperinflammatory response („cytokine storm“) present in septic shock and other, non-infectious systemic hyperinflammatory states by reducing elevated levels of cytokines and other inflammatory mediators. This modulation of the immune response can lead to an improvement of hemodynamics, a reduction in the need for vasopressors and overall to an increased chance for recovery of organ functions and improved patient outcomes. CytoSorb is indicated in various hyperinflammatory states of infectious and non-infectious origin, e.g. after cardiac surgery, in cardiogenic shock, trauma, burns, pancreatitis and infection. So far it has been used safely and well tolerated in more than 27,000 single treatments worldwide. CytoSorb Therapy – REGAIN CONTROL!